Hofseth BioCare ASA 2020 AR2
The report details Hofseth BioCare's financial and sustainability performance for the fiscal year 2020. The company made significant progress in its transition to a biotechnology company, securing key health claim approvals from Health Canada and the US FDA for its marine ingredients. Hofseth BioCare continued its commitment to circular economy principles by upcycling fish off-cuts into high-value human and animal nutrition products. On the environmental front, the company installed energy-saving systems at its Midsund factory, reducing energy consumption. It also established an external whistleblowing channel and updated its Code of Conduct to strengthen corporate governance.
Company: Hofseth BioCare ASA
Sector: Manufacturing
Country: Norway
Year: 2020
Type: AR2
Pages: 86
Back to company
Hofseth BioCare ASA
Annual Report
The report details Hofseth BioCare's financial and sustainability performance for the fiscal year 2020. The company made significant progress in its transition to a biotechnology company, securing key health claim approvals from Health Canada and the US FDA for its marine ingredients. Hofseth BioCare continued its commitment to circular economy principles by upcycling fish off-cuts into high-value human and animal nutrition products. On the environmental front, the company installed energy-saving systems at its Midsund factory, reducing energy consumption. It also established an external whistleblowing channel and updated its Code of Conduct to strengthen corporate governance.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2020
Reporting Period
Jan 1, 2020 - Dec 31, 2020
Fiscal Year
2020
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
ESG Data?Experimental: AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Total Waste
Women on Board
Workplace Fatalities
Employees